These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 16087720)

  • 1. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.
    Kooptiwut S; Zraika S; Thorburn AW; Dunlop ME; Darwiche R; Kay TW; Proietto J; Andrikopoulos S
    Endocrinology; 2002 Jun; 143(6):2085-92. PubMed ID: 12021173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
    Weinhaus AJ; Stout LE; Sorenson RL
    Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets.
    Zraika S; Aston-Mourney K; Laybutt DR; Kebede M; Dunlop ME; Proietto J; Andrikopoulos S
    Diabetologia; 2006 Jun; 49(6):1254-63. PubMed ID: 16570159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture.
    Liang Y; Najafi H; Smith RM; Zimmerman EC; Magnuson MA; Tal M; Matschinsky FM
    Diabetes; 1992 Jul; 41(7):792-806. PubMed ID: 1612193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
    Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
    Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems for attenuated insulin release.
    Svensson C; Welsh N; Krawetz SA; Welsh M
    Diabetes; 1991 Jun; 40(6):771-6. PubMed ID: 1645683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Islet Glucokinase, Glucose Metabolism, and Insulin Pathway in the Enhancing Effect of Islet Neogenesis-Associated Protein on Glucose-Induced Insulin Secretion.
    Maiztegui B; Román CL; Barbosa-Sampaio HC; Boschero AC; Gagliardino JJ
    Pancreas; 2015 Aug; 44(6):959-66. PubMed ID: 25906449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products downregulate glucokinase in mice.
    Jung H; Joo J; Jeon Y; Lee J; In J; Kim D; Kang E; Kim Y; Lim Y; Kang J; Choi J
    Diabetes Metab Res Rev; 2011 Sep; 27(6):557-63. PubMed ID: 21538775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose regulates glucokinase activity in cultured islets from rat pancreas.
    Liang Y; Najafi H; Matschinsky FM
    J Biol Chem; 1990 Oct; 265(28):16863-6. PubMed ID: 2211598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.
    Liang Y; Bonner-Weir S; Wu YJ; Berdanier CD; Berner DK; Efrat S; Matschinsky FM
    J Clin Invest; 1994 Jun; 93(6):2473-81. PubMed ID: 8200983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glucose-stimulated insulin release by pseudo-alpha-DL-glucose as a glucokinase inhibitor.
    Miwa I; Hara H; Okuda J; Suami T; Ogawa S
    Biochem Int; 1985 Dec; 11(6):809-16. PubMed ID: 3911958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.
    Radu RG; Fujimoto S; Mukai E; Takehiro M; Shimono D; Nabe K; Shimodahira M; Kominato R; Aramaki Y; Nishi Y; Funakoshi S; Yamada Y; Seino Y
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E365-71. PubMed ID: 15479952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
    Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
    Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimato T; Umeda F; Nawata H
    Pancreas; 2002 Apr; 24(3):228-34. PubMed ID: 11893929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.